Pay in 4 interest-free payments of $7.00 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
Phase 2 trial data (Jastreboff et al., NEJM 2023) demonstrated average weight reductions of approximately 1724% over 48 weeks notably higher than currently approved GLP-1 receptor agonists such as semaglutide, though direct comparisons are limited by differences in trial populations and designs
The benefit of this is that this higher dose can be injected in one shot and the benefits of B12 supplementation may be felt sooner
NAC Injection HOMEKIT Mood/Inflammation/Fatigue $269.00 Sale
AOD-9604 administers subcutaneously, meaning into the fat layer just beneath the skin
US$ 20.86
US$ 25.79
US$ 25.40
US$ 28.43
US$ 25.56
US$ 27.17
US$ 24.50
US$ 27.42
US$ 22.39
